Decanoic Acid

Decanoic Acid

SCHEMBL580470

CCCCCCCCCC(=O)[O-].C[N+](C)(C)CCO

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Decanoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 7/20 0.55
CA1 P00915 1/20 0.52
BBOX1 O75936 2/20 0.48
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nonanoate SCHEMBL29370695 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Stearic Acid SCHEMBL840883 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Dodecanoate SCHEMBL19253062 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Palmitic Acid SCHEMBL10396224 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Octanoic Acid SCHEMBL2761867 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Myristic Acid SCHEMBL8588822 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Stearic Acid SCHEMBL3459529 0.98 FABP3 (0.53) FABP3CA1BBOX1CES2CES1
Myristic Acid SCHEMBL5317287 0.98 FABP3 (0.53) FABP3CA1BBOX1CES2CES1
Dodecanoate SCHEMBL5320074 0.98 FABP3 (0.53) FABP3CA1BBOX1CES2CES1
Decanoic Acid SCHEMBL5318916 0.98 FABP3 (0.53) FABP3CA1BBOX1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034075-A1 CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS UNIV MISSISSIPPI (US) 2026-02-05 US claimed
CN-119798586-A Preparation method of polyisocyanate composition 万华化学集团股份有限公司 2025-04-11 CN claimed
CN-118165226-A Preparation method of polyisocyanate composition 万华化学(宁波)有限公司 2024-06-11 CN claimed
CN-118165221-A Allophanate composition, polyisocyanate composition, and preparation methods and applications thereof 万华化学(宁波)有限公司 2024-06-11 CN claimed
CN-118058284-A Fatty acid choline salt soluble solution and preparation method and application thereof 郑州郑氏化工产品有限公司 2024-05-24 CN claimed
WO-2024030844-A1 CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS UNIVERSITY OF MISSISSIPPI (US) 2024-02-08 WO claimed
CN-113698572-B Polyisocyanate composition, preparation method and application 万华化学(宁波)有限公司 2023-12-19 CN claimed
CN-116854890-A Preparation method of polyisocyanate composition 万华化学集团股份有限公司 2023-10-10 CN claimed
CN-115246793-B Preparation method of diisocyanate trimer, catalyst and preparation method thereof 山东新和成精化科技有限公司 2023-07-07 CN claimed
CN-113265037-B Polyisocyanate composition and preparation method and application thereof 万华化学(宁波)有限公司 2023-03-24 CN claimed
WO-2022241616-A1 POLYISOCYANATE COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 万华化学(宁波)有限公司 2022-11-24 WO claimed
CN-115246793-A Preparation method of diisocyanate trimer, catalyst and preparation method thereof 山东新和成精化科技有限公司 2022-10-28 CN claimed
CN-113698572-A Polyisocyanate composition, preparation method and application 万华化学(宁波)有限公司 2021-11-26 CN claimed
EP-3883382-A1 COMPOSITION COMPRISING A CHOLINE SALT OF A FATTY ACID AND ITS USE AS A FUNGICIDE BIPA NV (BE) 2021-09-29 EP claimed
CN-113265037-A Polyisocyanate composition and preparation method and application thereof 万华化学(宁波)有限公司 2021-08-17 CN claimed
CN-113163761-A Compositions comprising choline salts of fatty acids and their use as fungicides 比帕股份有限公司 2021-07-23 CN claimed
US-20260034075-A1 CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS UNIV MISSISSIPPI (US) 2026-02-05 US disclosed
US-12446577-B2 Composition comprising a choline salt of a fatty acid and its use as a fungicide BIPA NV (BE) 2025-10-21 US disclosed
EP-2417225-A2 PROCESS FOR REMOVING METALS FROM HYDROCARBONS Petroliam Nasional Berhad (PETRONAS) (MY) 2012-02-15 EP disclosed
WO-2010116165-A2 PROCESS FOR REMOVING METALS FROM HYDROCARBONS PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034075-A1 CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS ELOVL3, L3MBTL3, ELOVL6 FABP3 79/4885CA1 1831/4885BBOX1 3660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.